A PCR-independent approach for mtDNA enrichment and next-generation sequencing: comprehensive evaluation and clinical

Dong Liang1, Lin Zhu2, Yuqing Zhu1

  • 1Department of Prenatal Diagnosis, Women's Hospital of Nanjing Medical University, Nanjing Women and Children's Healthcare Hospital, Nanjing, 210004, China.

PubMed
Abstract

Insights

Pime-Seq, a novel PCR-independent method, enables high-quality mitochondrial DNA sequencing. This approach reliably detects mitochondrial DNA variants, proving effective for both clinical diagnosis and research in mitochondrial genetics.

Area of Science:

  • Genomics
  • Molecular Biology
  • Medical Genetics

Background:

  • Mitochondrial genome sequencing is crucial for understanding primary mitochondrial diseases (PMD) and mitochondrial genetics.
  • Traditional PCR-based enrichment methods for mitochondrial DNA (mtDNA) have limitations.
  • A PCR-independent approach, Pime-Seq, was developed to address these limitations.

Purpose of the Study:

  • To develop and evaluate Pime-Seq, a PCR-independent method for mtDNA enrichment and next-generation sequencing.
  • To assess the accuracy, reliability, and clinical utility of Pime-Seq for detecting mtDNA variants.

Main Methods:

  • Developed and optimized Pime-Seq, a PCR-independent mtDNA enrichment technique.
  • Compared Pime-Seq with long-range PCR (lrPCR) based next-generation sequencing (NGS) on 45 samples.
  • Applied Pime-Seq retrospectively on PMD patient samples and prospectively in prenatal screening.

Main Results:

  • Pime-Seq achieved a high mtDNA reads ratio (88.0 ± 7.9%) in sequencing libraries from human PBMC samples.
  • Pime-Seq demonstrated high consistency among technical repeats and superior reliability compared to lrPCR-based NGS for low-level heteroplasmic variants.
  • Successfully detected all pathogenic mtDNA variants in PMD patients and identified pathogenic variants in 4 out of 192 pregnant women during prenatal screening.

Conclusions:

  • Pime-Seq provides highly enriched mtDNA in a PCR-independent manner for high-quality, reliable deep-sequencing.
  • This method is an effective and promising tool for detecting mtDNA variants in both clinical and research settings.
  • Pime-Seq enhances diagnostic capabilities for mitochondrial disorders and offers valuable information for health monitoring.

Related Concept Videos

Next-generation Sequencing03:00

Next-generation Sequencing

The first human genome sequencing project cost $2.7 billion and was declared complete in 2003, after 15 years of international cooperation and collaboration between several research teams and funding agencies. Today, with the advent of next-generation sequencing technologies, the cost and time of sequencing a human genome have dropped over 100 fold.
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features....
88.7K
DNA Isolation01:24

DNA Isolation

DNA isolation protocols can be fast and straightforward or complex and time-consuming depending on the type and quality of DNA required for further processing. For example, plasmid DNA extraction is a bit more complicated than genomic DNA extraction because of the need for an appropriate lysis method to separate plasmid DNA from gDNA during isolation. However, for specific applications, such as long-range DNA sequencing that require a good yield of high- quality DNA samples, we need to follow...
38.9K
RNA-seq03:21

RNA-seq

RNA sequencing, or RNA-Seq, is a high-throughput sequencing technology used to study the transcriptome of a cell. Transcriptomics helps to interpret the functional elements of a genome and identify the molecular constituents of an organism. Additionally, it also helps in understanding the development of an organism and the occurrence of diseases. 
Before the discovery of RNA-seq, microarray-based methods and Sanger sequencing were used for transcriptome analysis. However, while...
9.9K